Talarozole inhibits the metabolism of [[retinoic acid]] by blocking [[cytochrome P450]] enzyme CYP26 [[isoenzyme]]s ([[CYP26A1]] and possibly also [[CYP26B1]]), retinoic acid [[hydroxylase]]s.<ref name="pmid23688132">{{cite journal | vauthors = Nelson CH, Buttrick BR, Isoherranen N | title = Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics | journal = Curr Top Med Chem | volume = 13 | issue = 12 | pages = 1402–28 | year = 2013 | pmid = 23688132 | pmc = 4366427 | doi = | url = }}</ref> Because of this mechanism, it is called a [[retinoic acid metabolism blocking agent]] (RAMBA).<ref name="pmid23688132" /><ref name="pmid19120344">{{cite journal|last=Giltaire|first=S|author2=Herphelin F |author3=Frankart A |author4=Hérin M |author5=Stoppie P |author6=Poumay Y |date=11 December 2008|title=The CYP26 inhibitor R115866 potentiates the effects of all-trans retinoic acid on cultured human epidermal keratinocytes|journal=Br J Dermatol|pmid=19120344|volume=160|issue=3|pages=505–13|doi=10.1111/j.1365-2133.2008.08960.x}}</ref>
